Résultats de la recherche - 4 results
Clinical Evolution and Disease Burden in Belgian Cystic Fibrosis Patients: effect of Newborn Screening?
months, IQR 0.00-0.36 months) but lower in NBS patients (median 1.38 months, IQR 0.82-1.74 months) compared to non- NBS patients (8.01 months, IQR 2.47-37.58 months, p-value < 0.001). Height z-scores at ...
Annual Report Belgian Cystic Fibrosis Registry 2018
in 2018, among them five adults, with a median age at diagnosis of 9.8 months and age range from birth to 70.6 years. All the newly diagnosed patients were genotyped; 18 had sweat chloride values > ...
Annual Report Belgian Cystic Fibrosis Registry 2017
genotyped; 34 had sweat chloride values > 60 mmol/L. Among the patients followed-up in 2017, 51.8% were male and 62.2% adults, and the median age was 22.8 years. Interestingly, at the start of the registry, ...
Risk factors and impact of allergic bronchopulmonary aspergillosis in Pseudomonas aeruginosa-negative CF patients.
mutation (homozygous or heterozygous), and Pa colonization. RESULTS: Median FEV at the year of diagnosis (index year) was significantly lower in patients with ABPA. The median of cumulative values of FEV and ...